Form 4: Castle Biosciences Director Mara G. Aspinall Reports Stock Transaction
SEC Filing
Director Mara G. Aspinall reports the vesting and subsequent disposal of 8,636 restricted stock units of Castle Biosciences on May 23, 2024.
Summary
- On May 23, 2024, Mara G. Aspinall, a director of Castle Biosciences, Inc., had 8,636 Restricted Stock Units (RSUs) vest.
- These RSUs were granted on May 25, 2023, under the 'Non Employee Director Compensation Policy'.
- Each RSU represents the right to receive one share of Castle Biosciences' Common Stock.
- Following the vesting, Aspinall disposed of the 8,636 shares.
- After the reported transaction, Aspinall beneficially owns 44,139 shares of Castle Biosciences.
Sentiment
Score: 5
Explanation: This is a routine disclosure of a stock transaction by a company director, with no inherent positive or negative implications.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This provides transparency to the market.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/25/2023 | Date of grant of restricted stock units to the Reporting Person under the 'Non Employee Director Compensation Policy'. |
| 05/23/2024 | Date of transaction: vesting and disposal of 8,636 Restricted Stock Units. |
| 06/04/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.